Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Russell

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
BMJ Open|March 4, 2018
CoMET: a protocol for a randomised controlled trial of co-commencement of METformin as an adjunctive treatment to attenuate weight gain and metabolic syndrome in patients with schizophrenia newly commenced on clozapineDan Siskind, Nadia Friend, Anthony Russell, et al.
Journal of Medical Economics|January 2, 2025
Cost-utility analysis of empagliflozin for heart failure in the PhilippinesPrecious Juzenda Montilla, Camilo Oliver Aquino, Elaine Cunanan, et al.
Journal of Medical Economics|May 17, 2025
Cost-of-illness of heart failure with preserved and reduced ejection fraction in the PhilippinesJohn Añonuevo, Camilo Oliver Aquino, Elaine Cunanan, et al.
The New England Journal of Medicine|November 14, 2003
Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4IgJoel M Kremer, Rene Westhovens, Marc Leon, et al.
Internal Medicine Journal|December 12, 2022
Secular trends in the utility of SGLT-2 inhibitors in heart failure patients with type 2 diabetes mellitus across Metro South Health hospitals in South-East QueenslandZhen Qi Lu, Elizabeth McCourt, Karen Goodhew, et al.
Journal of Medical Economics|December 24, 2025
Cost-effectiveness analysis of empagliflozin as an add-on to the standard of care for chronic kidney disease management in the PhilippinesPrecious Juzenda Montilla, Arlene Cabotaje Crisostomo, Elaine Cunanan, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|March 31, 2025
Buffered salt solution versus 0.9% sodium chloride as fluid therapy for patients presenting with moderate to severe diabetic ketoacidosis: Study protocol for a Phase-3 cluster-crossover, blinded, randomised, controlled trialMahesh Ramanan, Dorrilyn Rajbhandari, Carolyn Koch, et al.
Journal of Medical Economics|March 24, 2025
Cost-of-illness analysis of chronic kidney disease (CKD) management in the PhilippinesAnthony Russell Villanueva, Donnah de Leon, Patrick James Encarnacion, et al.
Diabetologia|June 6, 2018
Corneal confocal microscopy for identification of diabetic sensorimotor polyneuropathy: a pooled multinational consortium studyBruce A Perkins, Leif E Lovblom, Vera Bril, et al.
Diabetes Care|July 2, 2021
Corneal Confocal Microscopy Predicts the Development of Diabetic Neuropathy: A Longitudinal Diagnostic Multinational Consortium StudyBruce A Perkins, Leif Erik Lovblom, Evan J H Lewis, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
BMJ Open|March 4, 2018
CoMET: a protocol for a randomised controlled trial of co-commencement of METformin as an adjunctive treatment to attenuate weight gain and metabolic syndrome in patients with schizophrenia newly commenced on clozapineDan Siskind, Nadia Friend, Anthony Russell, et al.
Journal of Medical Economics|January 2, 2025
Cost-utility analysis of empagliflozin for heart failure in the PhilippinesPrecious Juzenda Montilla, Camilo Oliver Aquino, Elaine Cunanan, et al.
Journal of Medical Economics|May 17, 2025
Cost-of-illness of heart failure with preserved and reduced ejection fraction in the PhilippinesJohn Añonuevo, Camilo Oliver Aquino, Elaine Cunanan, et al.
The New England Journal of Medicine|November 14, 2003
Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4IgJoel M Kremer, Rene Westhovens, Marc Leon, et al.
Internal Medicine Journal|December 12, 2022
Secular trends in the utility of SGLT-2 inhibitors in heart failure patients with type 2 diabetes mellitus across Metro South Health hospitals in South-East QueenslandZhen Qi Lu, Elizabeth McCourt, Karen Goodhew, et al.
Journal of Medical Economics|December 24, 2025
Cost-effectiveness analysis of empagliflozin as an add-on to the standard of care for chronic kidney disease management in the PhilippinesPrecious Juzenda Montilla, Arlene Cabotaje Crisostomo, Elaine Cunanan, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|March 31, 2025
Buffered salt solution versus 0.9% sodium chloride as fluid therapy for patients presenting with moderate to severe diabetic ketoacidosis: Study protocol for a Phase-3 cluster-crossover, blinded, randomised, controlled trialMahesh Ramanan, Dorrilyn Rajbhandari, Carolyn Koch, et al.
Journal of Medical Economics|March 24, 2025
Cost-of-illness analysis of chronic kidney disease (CKD) management in the PhilippinesAnthony Russell Villanueva, Donnah de Leon, Patrick James Encarnacion, et al.
Diabetologia|June 6, 2018
Corneal confocal microscopy for identification of diabetic sensorimotor polyneuropathy: a pooled multinational consortium studyBruce A Perkins, Leif E Lovblom, Vera Bril, et al.
Diabetes Care|July 2, 2021
Corneal Confocal Microscopy Predicts the Development of Diabetic Neuropathy: A Longitudinal Diagnostic Multinational Consortium StudyBruce A Perkins, Leif Erik Lovblom, Evan J H Lewis, et al.
Pageof 9